A brain computer interface platform company leading the field of implantable neural interface technology.
You can scroll over the chart's area to move in time and tap to see a specific date.
Highest Bid
$ 260.80
Lowest Offer
$ 188.50
Last Trade
$ 234.00
Live Orders
1,298
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Synchron is a brain computer interface platform company leading the field of implantable neural interface technology, pioneering the development of endovascular minimally invasive neuroprostheses for the treatment of paralysis.
Synchron Funding
Sign up to gain insights into Synchron funding history, including the funding round, time period, and amount raised.
| Financing Round | Date | Amount | Price per share | Valuation |
|---|---|---|---|---|
| Round | Date | Amount | PPS | Valuation |
| Series C | Dec 15, 2022 | 75M | ||
| Series B | Jun 03, 2021 | 4M | ||
| Series B | Jun 03, 2021 | 36M | ||
| Series A | Apr 04, 2017 | 10M |
Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market Tape D®
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Synchron Management Team
Investors
Forepont Capital Partners
University of Melbourne
Neurotechnology Investors (NTI)
General Advance
Alumni Ventures
Project X
Subversive Capital
Reliance Digital Health Limited
Gates Frontier
Shanda Group
ID8 Investments
Khosla Ventures
Moore Strategic Ventures
Greenoaks
Bezos Expeditions
METIS
Khosla Ventures
ARCH Venture Partners
Synchron Valuations & Financials
View real-time NPM data on Synchron stock including most recent valuation and historical share price information. Are you an institutional investor or employee shareholder? Sign up to the SecondMarket trading platform.
Similar Companies
like Synchron
Cerebral
Health Care
Telemedicine mental health startup, providing evidence-based therapeutic techniques and medication management.
Virta Health
Health Care
Online specialty medical clinic focused on reversing type 2 diabetes.
Color Genomics
Health Care
Physician-ordered genetic testing with comprehensive support, utilizing advanced software and a certified laboratory.
Somatus
Health Care
Integrated care for patients with or at risk of developing kidney disease.
Curology
Health Care
Offers personalized prescription skin care medications delivered directly to you.
Eikon Therapeutics
Health Care
Uses revolutionary technology to discover novel treatments for life-threatening diseases.
Benchling
Health Care
Cloud based platform for research and development in biotechnology.
FAQ
We have answers
Synchron stock does not trade on public stock exchanges. Synchron stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Synchron stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Synchron Stock does not trade on public stock exchanges. In order to sell Synchron shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Nasdaq Private Market estimates that Synchron price per share was $40.2 last month. This Synchron share value estimate (known as the Tape D™ price) is based on market activity, publicly-sourced valuation data, and other proprietary information. With Tape D premium for investors, you can get visibility into the Synchron share price today and the factors driving Synchron valuation estimates. Learn more about premium data here.
Read more about private company stock prices: Understanding the Bid-Ask Spread: How Buyers and Sellers Match on Price
There is no ticker symbol for Synchron stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Synchron stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Synchron stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Synchron is a private company and has not had an IPO. There is currently no Synchron IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Synchron IPO.
Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.
